• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳入公共规划疫苗的标准。

Criteria for inclusion of vaccinations in public programmes.

机构信息

Health Council of the Netherlands, The Hague, The Netherlands.

出版信息

Vaccine. 2010 Apr 9;28(17):2924-31. doi: 10.1016/j.vaccine.2010.02.021. Epub 2010 Feb 26.

DOI:10.1016/j.vaccine.2010.02.021
PMID:20189486
Abstract

As more and more new vaccines are developed and brought to the market, governments have to make decisions about which vaccinations to include in public programmes. This paper describes the experience in the Netherlands in developing a framework for assessing whether a vaccination should be included in the National Immunization Programme (NIP). Bearing in mind the public nature, the factors that determine a vaccine's suitability for inclusion in a communal vaccination programme have been translated into seven selection criteria, grouped under five thematic headings: seriousness and extent of the disease burden, effectiveness and safety of the vaccination, acceptability of the vaccination, efficiency of the vaccination, and priority of the vaccination. The seven criteria and the explanation of them provide a framework for the systematic examination of arguments for and against the inclusion and prioritisation of particular vaccinations. As an illustration, the vaccinations currently provided in the Netherlands through public programmes as well as 23 'candidate' vaccinations are assessed against the seven criteria. The proposed assessment framework including the selection criteria can take full account of the values and specificities as they may differ between situations and countries; the transparency of the approach may help to clarify which elements of the assessment are pivotal in specific situations. Using the criteria furthers a trustworthy, transparent and accountable process of decision-making about inclusion of new vaccinations in public vaccination programmes and may help to retain public confidence.

摘要

随着越来越多的新型疫苗被开发并推向市场,政府必须就哪些疫苗应纳入公共计划做出决策。本文介绍了荷兰在制定评估疫苗是否应纳入国家免疫规划(NIP)的框架方面的经验。考虑到公共性质,决定疫苗是否适合纳入社区疫苗接种计划的因素已被转化为七个选择标准,分为五个主题类别:疾病负担的严重程度和范围、疫苗的有效性和安全性、疫苗的可接受性、疫苗的效率以及疫苗的优先顺序。这七个标准及其解释为系统审查纳入和优先考虑特定疫苗的理由提供了一个框架。作为说明,根据这七个标准评估了目前通过公共计划在荷兰提供的疫苗以及 23 种“候选”疫苗。所提出的评估框架包括选择标准,可以充分考虑到不同情况下价值观和具体情况的差异;该方法的透明度有助于澄清在特定情况下评估的哪些要素是关键的。使用这些标准可以促进新疫苗纳入公共疫苗接种计划的值得信赖、透明和负责任的决策过程,并有助于保持公众的信心。

相似文献

1
Criteria for inclusion of vaccinations in public programmes.纳入公共规划疫苗的标准。
Vaccine. 2010 Apr 9;28(17):2924-31. doi: 10.1016/j.vaccine.2010.02.021. Epub 2010 Feb 26.
2
Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.荷兰的乙型肝炎公共疫苗接种计划:评估目标人群策略还是普遍接种策略更为合适。
Vaccine. 2010 Nov 16;28(49):7723-30. doi: 10.1016/j.vaccine.2010.09.068. Epub 2010 Oct 14.
3
Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.
Vaccine. 2006 May 29;24(22):4769-78. doi: 10.1016/j.vaccine.2006.03.022. Epub 2006 Mar 27.
4
Comparison of NITAG policies and working processes in selected developed countries.部分发达国家国家免疫技术咨询小组(NITAG)政策与工作流程比较
Vaccine. 2015 Jan 1;33(1):3-11. doi: 10.1016/j.vaccine.2014.09.023. Epub 2014 Sep 23.
5
Decision support in vaccination policies.疫苗接种政策中的决策支持。
Vaccine. 2009 Oct 9;27(43):5923-8. doi: 10.1016/j.vaccine.2009.07.105. Epub 2009 Aug 19.
6
Strategies for decision-making on vaccine use: the French experience.疫苗使用决策策略:法国的经验。
Expert Rev Vaccines. 2015 Jul;14(7):917-22. doi: 10.1586/14760584.2015.1035650. Epub 2015 Apr 25.
7
Policy analysis: an essential research tool for the introduction of vaccines in developing countries.政策分析:发展中国家引入疫苗的一项重要研究工具。
J Health Popul Nutr. 2004 Sep;22(3):331-7.
8
[Universal vaccination against group-C meningococci and pneumococci; summary of the advice from the Health Counsil of the Netherlands].
Ned Tijdschr Geneeskd. 2002 May 18;146(20):938-40.
9
A critique of criteria for evaluating vaccines for inclusion in mandatory school immunization programs.对纳入学校强制性免疫规划的疫苗评估标准的批判
Pediatrics. 2008 Aug;122(2):e504-10. doi: 10.1542/peds.2007-3218.
10
[The contribution of social medicine to vaccination in Austria].[社会医学对奥地利疫苗接种的贡献]
Wien Med Wochenschr. 1998;148(8-9):191-7.

引用本文的文献

1
A literature review and evidence-based evaluation of the Dutch national immunisation schedule yield possibilities for improvements.一项关于荷兰国家免疫规划的文献综述及基于证据的评估揭示了改进的可能性。
Vaccine X. 2024 Sep 26;20:100556. doi: 10.1016/j.jvacx.2024.100556. eCollection 2024 Oct.
2
Construction of an indicator framework for vaccine inclusion in public health programs: A Delphi-entropy method study.构建公共卫生规划中疫苗纳入的指标框架:德尔菲-熵法研究。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2272539. doi: 10.1080/21645515.2023.2272539. Epub 2023 Oct 31.
3
Parents' and healthcare professionals' perception toward the introduction of a new fully liquid hexavalent vaccine in the Malaysian national immunization program: a cross-sectional study instrument development and its application.
家长和医疗保健专业人员对马来西亚国家免疫计划中引入新型全液体六价疫苗的看法:横断面研究工具的开发及其应用。
Front Immunol. 2023 Apr 27;14:1052450. doi: 10.3389/fimmu.2023.1052450. eCollection 2023.
4
Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.推动国家免疫规划更多使用世界卫生组织推荐疫苗:中国面临的问题与挑战。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2194190. doi: 10.1080/21645515.2023.2194190. Epub 2023 Apr 26.
5
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella.在经济评估中考虑免疫接种后的不良事件:对预防肺炎球菌、轮状病毒、人乳头瘤病毒、脑膜炎球菌以及麻疹-腮腺炎-风疹-水痘的儿科疫苗经济评估的系统评价
Pharmacoeconomics. 2023 May;41(5):481-497. doi: 10.1007/s40273-023-01252-z. Epub 2023 Feb 21.
6
[Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra].[针对意大利儿童使用四价流感裂解疫苗(Fluenz Tetra)接种流感疫苗的卫生技术评估]
J Prev Med Hyg. 2021 Sep 10;62(2 Suppl 1):E1-E118. doi: 10.15167/2421-4248/jpmh2021.62.2s1. eCollection 2021 Jun.
7
Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost.荷兰国家免疫规划中婴儿轮状病毒疫苗接种延迟且受限:错失的机遇
Vaccines (Basel). 2021 Feb 10;9(2):144. doi: 10.3390/vaccines9020144.
8
Vaccinating for Whom? Distinguishing between Self-Protective, Paternalistic, Altruistic and Indirect Vaccination.为谁接种疫苗?区分自我保护型、家长主义型、利他型和间接接种型疫苗
Public Health Ethics. 2020 Mar 11;13(2):190-200. doi: 10.1093/phe/phaa005. eCollection 2020 Jul.
9
Value Frameworks for Vaccines: Which Dimensions Are Most Relevant?疫苗的价值框架:哪些维度最为相关?
Vaccines (Basel). 2020 Oct 28;8(4):628. doi: 10.3390/vaccines8040628.
10
Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.给儿童接种流感疫苗:总体具有成本效益,但存在不良后果的可能性。
BMC Med. 2020 Jan 14;18(1):11. doi: 10.1186/s12916-019-1471-x.